Clinical TrialsGENFIT Reports Positive Results for GNS561 Combination in KRAS-Mutated Chol... GENFIT Reports Positive Results for GNS561 Combination in KRAS-Mutated Chol... Read Post »
Health Tidings Mergers & AcquisitionsMerck KGaA to Acquire Bio-Techne for $11.3 Billion to Expand Life Science P... Merck KGaA to Acquire Bio-Techne for $11.3 Billion to Expand Life Science P... Read Post »
Health TidingsRecce Raises A$4 Million to Advance R327 Trial in DFI Recce Raises A$4 Million to Advance R327 Trial in DFI Read Post »
Health TidingsMHRA Validates Eisai’s Taletrectinib for ROS1-Positive Lung Cancer MHRA Validates Eisai’s Taletrectinib for ROS1-Positive Lung Cancer Read Post »
Health Tidings Mergers & AcquisitionsNovartis Partners With Antares in Up to $1.9 Billion Oncology Drug Deal Novartis Partners With Antares in Up to $1.9 Billion Oncology Drug Deal Read Post »
Health TidingsMHRA Approves Pediatric Investigation Plan for Ebstrocel in RDEB MHRA Approves Pediatric Investigation Plan for Ebstrocel in RDEB Read Post »
New Drug ApprovalFDA Approves KEYTRUDA Plus Trodelvy for First-Line Advanced Triple-Negative... FDA Approves KEYTRUDA Plus Trodelvy for First-Line Advanced Triple-Negative... Read Post »
Clinical TrialsCentanafadine Improves ADHD and Anxiety Symptoms in Phase 3b Trial Ahead of... Centanafadine Improves ADHD and Anxiety Symptoms in Phase 3b Trial Ahead of... Read Post »
Health Tidings Mergers & AcquisitionsIonis Partners with Recordati to Commercialize Zilganersen for Alexander Di... Ionis Partners with Recordati to Commercialize Zilganersen for Alexander Di... Read Post »
Clinical TrialsCeleCor Submits NDA for Zalunfiban After Positive CeleBrate Trial Results CeleCor Submits NDA for Zalunfiban After Positive CeleBrate Trial Results Read Post »
Clinical TrialsHUTCHMED Reports Positive Results for Fanregratinib in FGFR2-Altered Intrah... HUTCHMED Reports Positive Results for Fanregratinib in FGFR2-Altered Intrah... Read Post »
Clinical TrialsAvacta Reports Positive Data for Faridoxorubicin in Salivary Gland Cancer Avacta Reports Positive Data for Faridoxorubicin in Salivary Gland Cancer Read Post »
Health TidingsOllin Raises $330 Million to Advance Phase 3 Trials of VEGF/Ang2 Bispecific... Ollin Raises $330 Million to Advance Phase 3 Trials of VEGF/Ang2 Bispecific... Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly Expands Abbisko Alliance in Up to $1.9 Billion Multi-Target Drug ... Eli Lilly Expands Abbisko Alliance in Up to $1.9 Billion Multi-Target Drug ... Read Post »
New Drug ApprovalTrodelvy Wins FDA Approval for First-Line mTNBC After EU Approval Trodelvy Wins FDA Approval for First-Line mTNBC After EU Approval Read Post »
New Drug ApprovalFDA Approves IBRANCE for HR+/HER2+ Metastatic Breast Cancer FDA Approves IBRANCE for HR+/HER2+ Metastatic Breast Cancer Read Post »
New Drug ApprovalFDA Approves TRYNGOLZA (Olezarsen) to Reduce Triglycerides and Acute Pancre... FDA Approves TRYNGOLZA (Olezarsen) to Reduce Triglycerides and Acute Pancre... Read Post »
Health TidingsFDA Converts Tecelra to Full Approval, Broadens Label to Adolescents FDA Converts Tecelra to Full Approval, Broadens Label to Adolescents Read Post »
Health TidingsADC Therapeutics Cuts Workforce by 17% to Support ZYNLONTA Regulatory Expan... ADC Therapeutics Cuts Workforce by 17% to Support ZYNLONTA Regulatory Expan... Read Post »
Health TidingsFDA Clears Phase 3 Path for Entera’s Oral Osteoporosis Therapy EB613 FDA Clears Phase 3 Path for Entera’s Oral Osteoporosis Therapy EB613 Read Post »
Clinical TrialsCognition Aligns with FDA on Phase 3 Pathway for Zervimesine in Dementia wi... Cognition Aligns with FDA on Phase 3 Pathway for Zervimesine in Dementia wi... Read Post »
Clinical TrialsREGENXBIO Completes RGX-202 Confirmatory Study Enrollment, Advances Duchenn... REGENXBIO Completes RGX-202 Confirmatory Study Enrollment, Advances Duchenn... Read Post »
Health TidingsNICE Recommends Cemiplimab for Recurrent or Metastatic Cervical Cancer on t... NICE Recommends Cemiplimab for Recurrent or Metastatic Cervical Cancer on t... Read Post »
Clinical TrialsAbsci Reports Positive Phase 1 Interim Data for ABS-201, Advances Novel Hai... Absci Reports Positive Phase 1 Interim Data for ABS-201, Advances Novel Hai... Read Post »
Health Tidings Mergers & AcquisitionsNuvectis Adds Late-Stage NXP100 and NXP200 in Haisco Licensing Deal Nuvectis Adds Late-Stage NXP100 and NXP200 in Haisco Licensing Deal Read Post »
New Drug ApprovalPADCEV Plus Keytruda Wins EU Approval for Cisplatin-Ineligible MIBC PADCEV Plus Keytruda Wins EU Approval for Cisplatin-Ineligible MIBC Read Post »
GenericsFDA Approves First Generic Rifapentine Tablets for Active and Latent Tuberc... FDA Approves First Generic Rifapentine Tablets for Active and Latent Tuberc... Read Post »
Health TidingsFDA Modernizes Clinical Research Through Operation TrialBlazer FDA Modernizes Clinical Research Through Operation TrialBlazer Read Post »
Health TidingsBreakthrough T1D Backs MannKind’s INHALE-1ST Trial of Afrezza in Newly Di... Breakthrough T1D Backs MannKind’s INHALE-1ST Trial of Afrezza in Newly Di... Read Post »
Clinical TrialsVerastem Reports Encouraging Phase 1/2 Results for KRAS G12D Inhibitor VS-7... Verastem Reports Encouraging Phase 1/2 Results for KRAS G12D Inhibitor VS-7... Read Post »
New Drug ApprovalSanofi’s Wayrilz Wins Japan Approval for Chronic Immune Thrombocytopenia Sanofi’s Wayrilz Wins Japan Approval for Chronic Immune Thrombocytopenia Read Post »
Health TidingsGondolaBio Reports Positive Phase 2a Results for PORT-77 in EPP GondolaBio Reports Positive Phase 2a Results for PORT-77 in EPP Read Post »
New Drug ApprovalEU Authorizes MAVIRET for Adults and Children with Acute Hepatitis C EU Authorizes MAVIRET for Adults and Children with Acute Hepatitis C Read Post »
Clinical TrialsRevMed Advances Zoldonrasib into Phase 3 Pancreatic Cancer Trial RevMed Advances Zoldonrasib into Phase 3 Pancreatic Cancer Trial Read Post »
Health TidingsFDA Agrees on Phase 3 Plan for Galectin’s Belapectin in MASH Cirrhosi... FDA Agrees on Phase 3 Plan for Galectin’s Belapectin in MASH Cirrhosi... Read Post »
Health TidingsIMUNON Reports Positive Safety Review for Phase 3 IMNN-001 Ovarian Cancer S... IMUNON Reports Positive Safety Review for Phase 3 IMNN-001 Ovarian Cancer S... Read Post »
Clinical TrialsCorxel Reports Positive Results for Oral GLP-1 CX11 in Obesity Corxel Reports Positive Results for Oral GLP-1 CX11 in Obesity Read Post »
Clinical TrialsTScan Reports Strong Phase 1 Results for TSC-101 Ahead of Phase 3 Trial TScan Reports Strong Phase 1 Results for TSC-101 Ahead of Phase 3 Trial Read Post »
Health Tidings Mergers & AcquisitionsInsilico and SK Biopharmaceuticals Pursue New Neuroimmune Treatments Using ... Insilico and SK Biopharmaceuticals Pursue New Neuroimmune Treatments Using ... Read Post »
New Drug ApprovalSanofi Wins EU Approval for Cenrifki in Non-Relapsing SPMS Sanofi Wins EU Approval for Cenrifki in Non-Relapsing SPMS Read Post »
Clinical TrialsPP-01 Advances Toward Becoming First Approved Treatment for Cannabis Withdr... PP-01 Advances Toward Becoming First Approved Treatment for Cannabis Withdr... Read Post »
Clinical TrialsExelixis Reports Positive Final STELLAR-303 Survival Data in Metastatic Col... Exelixis Reports Positive Final STELLAR-303 Survival Data in Metastatic Col... Read Post »
Health TidingsFDA Rejects Cytisinicline NDA for Now, Requests Manufacturing Resolution FDA Rejects Cytisinicline NDA for Now, Requests Manufacturing Resolution Read Post »
Clinical TrialsFDA Grants Priority Review for Tivicay PD to Treat HIV in Newborns from Bir... FDA Grants Priority Review for Tivicay PD to Treat HIV in Newborns from Bir... Read Post »
Clinical TrialsPfizer’s Sigvotatug Vedotin Misses Overall Survival Endpoint in Phase 3 N... Pfizer’s Sigvotatug Vedotin Misses Overall Survival Endpoint in Phase 3 N... Read Post »
Health TidingsFDA Grants Rolling Review for QTORIN Rapamycin NDA in Rare Lymphatic Malfor... FDA Grants Rolling Review for QTORIN Rapamycin NDA in Rare Lymphatic Malfor... Read Post »
Health TidingsFDA Clears EAP for NRX-101 to Enhance TMS in Treatment-Resistant Depression FDA Clears EAP for NRX-101 to Enhance TMS in Treatment-Resistant Depression Read Post »
Health TidingsMedicus Showcases SkinJect and Teverelix Development Progress at BIO Intern... Medicus Showcases SkinJect and Teverelix Development Progress at BIO Intern... Read Post »
Clinical TrialsDefinium’s DT120 Succeeds in Phase 3 Trial for Major Depression Definium’s DT120 Succeeds in Phase 3 Trial for Major Depression Read Post »
Clinical TrialsBoehringer Advances Late-Stage Oncology Pipeline with Three Global Phase II... Boehringer Advances Late-Stage Oncology Pipeline with Three Global Phase II... Read Post »
